Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice

Todd W. Bauer, Wenbiao Liu, Fan Fan, Ernest R. Camp, Anthony Yang, Ray J. Somcio, Corazon D. Bucana, Jennifer Callahan, Graham C. Parry, Douglas B. Evans, Douglas D. Boyd, Andrew P. Mazar, Lee M. Ellis

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

Pancreatic carcinomas express high levels of urokinase-type plasminogen activator (uPA) and its receptor (uPAR), both of which mediate cell migration and invasion. We investigated the hypotheses that (a) insulin-like growth factor-I (IGF-I)-and hepatocyte growth factor (HGF)-mediated migration and invasion of human pancreatic carcinoma cells require uPA and uPAR function and (b) inhibition of uPAR inhibits tumor growth, retroperitoneal invasion, and hepatic metastasis of human pancreatic carcinomas in mice. Using transwell assays, we investigated the effect of IGF-I and HGF on L3.6pl migration and invasion. We measured the induction of uPA and uPAR following treatment of cells with IGF-I and HGF using immunoprecipitation and Western blot analysis. The importance of uPA and uPAR on L3.6pl cell migration and invasion was studied by inhibiting their activities with amiloride and antibodies before cytokine treatment. In an orthotopic mouse model of human pancreatic carcinoma, we evaluated the effect of anti-uPAR monoclonal antibodies with and without gemcitabine on primary tumor growth, retroperitoneal invasion, and hepatic metastasis. IGF-I and HGF mediated cell migration and invasion in L3.6pl cells. In addition, IGF-I and HGF induced uPA and uPAR expression in L3.6pl cells. In vitro, blockade of uPA and uPAR activity inhibited IGF-I- and HGF-mediated cell migration and invasion. Treatment of mice with anti-uPAR monoclonal antibody significantly decreased pancreatic tumor growth and hepatic metastasis and completely inhibited retroperitoneal invasion. Our study shows the importance of the uPA/uPAR system in pancreatic carcinoma cell migration and invasion. These findings suggest that uPAR is a potential target for therapy in patients with pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)7775-7781
Number of pages7
JournalCancer Research
Volume65
Issue number17
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Fingerprint

IGF Type 1 Receptor
Hepatocyte Growth Factor
Urokinase-Type Plasminogen Activator
Insulin-Like Growth Factor I
Cell Movement
Growth
Neoplasms
gemcitabine
Neoplasm Metastasis
Liver
Monoclonal Antibodies
Urokinase Plasminogen Activator Receptors
Amiloride
Therapeutics
Pancreatic Neoplasms
Immunoprecipitation
Pancreatic Carcinoma
human PLAUR protein
Western Blotting
Cytokines

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. / Bauer, Todd W.; Liu, Wenbiao; Fan, Fan; Camp, Ernest R.; Yang, Anthony; Somcio, Ray J.; Bucana, Corazon D.; Callahan, Jennifer; Parry, Graham C.; Evans, Douglas B.; Boyd, Douglas D.; Mazar, Andrew P.; Ellis, Lee M.

In: Cancer Research, Vol. 65, No. 17, 01.09.2005, p. 7775-7781.

Research output: Contribution to journalArticle

Bauer, Todd W. ; Liu, Wenbiao ; Fan, Fan ; Camp, Ernest R. ; Yang, Anthony ; Somcio, Ray J. ; Bucana, Corazon D. ; Callahan, Jennifer ; Parry, Graham C. ; Evans, Douglas B. ; Boyd, Douglas D. ; Mazar, Andrew P. ; Ellis, Lee M. / Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice. In: Cancer Research. 2005 ; Vol. 65, No. 17. pp. 7775-7781.
@article{6bcd9e304e154ca9af81b8c97a72ee78,
title = "Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice",
abstract = "Pancreatic carcinomas express high levels of urokinase-type plasminogen activator (uPA) and its receptor (uPAR), both of which mediate cell migration and invasion. We investigated the hypotheses that (a) insulin-like growth factor-I (IGF-I)-and hepatocyte growth factor (HGF)-mediated migration and invasion of human pancreatic carcinoma cells require uPA and uPAR function and (b) inhibition of uPAR inhibits tumor growth, retroperitoneal invasion, and hepatic metastasis of human pancreatic carcinomas in mice. Using transwell assays, we investigated the effect of IGF-I and HGF on L3.6pl migration and invasion. We measured the induction of uPA and uPAR following treatment of cells with IGF-I and HGF using immunoprecipitation and Western blot analysis. The importance of uPA and uPAR on L3.6pl cell migration and invasion was studied by inhibiting their activities with amiloride and antibodies before cytokine treatment. In an orthotopic mouse model of human pancreatic carcinoma, we evaluated the effect of anti-uPAR monoclonal antibodies with and without gemcitabine on primary tumor growth, retroperitoneal invasion, and hepatic metastasis. IGF-I and HGF mediated cell migration and invasion in L3.6pl cells. In addition, IGF-I and HGF induced uPA and uPAR expression in L3.6pl cells. In vitro, blockade of uPA and uPAR activity inhibited IGF-I- and HGF-mediated cell migration and invasion. Treatment of mice with anti-uPAR monoclonal antibody significantly decreased pancreatic tumor growth and hepatic metastasis and completely inhibited retroperitoneal invasion. Our study shows the importance of the uPA/uPAR system in pancreatic carcinoma cell migration and invasion. These findings suggest that uPAR is a potential target for therapy in patients with pancreatic cancer.",
author = "Bauer, {Todd W.} and Wenbiao Liu and Fan Fan and Camp, {Ernest R.} and Anthony Yang and Somcio, {Ray J.} and Bucana, {Corazon D.} and Jennifer Callahan and Parry, {Graham C.} and Evans, {Douglas B.} and Boyd, {Douglas D.} and Mazar, {Andrew P.} and Ellis, {Lee M.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1158/0008-5472.CAN-05-0946",
language = "English (US)",
volume = "65",
pages = "7775--7781",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "17",

}

TY - JOUR

T1 - Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice

AU - Bauer, Todd W.

AU - Liu, Wenbiao

AU - Fan, Fan

AU - Camp, Ernest R.

AU - Yang, Anthony

AU - Somcio, Ray J.

AU - Bucana, Corazon D.

AU - Callahan, Jennifer

AU - Parry, Graham C.

AU - Evans, Douglas B.

AU - Boyd, Douglas D.

AU - Mazar, Andrew P.

AU - Ellis, Lee M.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Pancreatic carcinomas express high levels of urokinase-type plasminogen activator (uPA) and its receptor (uPAR), both of which mediate cell migration and invasion. We investigated the hypotheses that (a) insulin-like growth factor-I (IGF-I)-and hepatocyte growth factor (HGF)-mediated migration and invasion of human pancreatic carcinoma cells require uPA and uPAR function and (b) inhibition of uPAR inhibits tumor growth, retroperitoneal invasion, and hepatic metastasis of human pancreatic carcinomas in mice. Using transwell assays, we investigated the effect of IGF-I and HGF on L3.6pl migration and invasion. We measured the induction of uPA and uPAR following treatment of cells with IGF-I and HGF using immunoprecipitation and Western blot analysis. The importance of uPA and uPAR on L3.6pl cell migration and invasion was studied by inhibiting their activities with amiloride and antibodies before cytokine treatment. In an orthotopic mouse model of human pancreatic carcinoma, we evaluated the effect of anti-uPAR monoclonal antibodies with and without gemcitabine on primary tumor growth, retroperitoneal invasion, and hepatic metastasis. IGF-I and HGF mediated cell migration and invasion in L3.6pl cells. In addition, IGF-I and HGF induced uPA and uPAR expression in L3.6pl cells. In vitro, blockade of uPA and uPAR activity inhibited IGF-I- and HGF-mediated cell migration and invasion. Treatment of mice with anti-uPAR monoclonal antibody significantly decreased pancreatic tumor growth and hepatic metastasis and completely inhibited retroperitoneal invasion. Our study shows the importance of the uPA/uPAR system in pancreatic carcinoma cell migration and invasion. These findings suggest that uPAR is a potential target for therapy in patients with pancreatic cancer.

AB - Pancreatic carcinomas express high levels of urokinase-type plasminogen activator (uPA) and its receptor (uPAR), both of which mediate cell migration and invasion. We investigated the hypotheses that (a) insulin-like growth factor-I (IGF-I)-and hepatocyte growth factor (HGF)-mediated migration and invasion of human pancreatic carcinoma cells require uPA and uPAR function and (b) inhibition of uPAR inhibits tumor growth, retroperitoneal invasion, and hepatic metastasis of human pancreatic carcinomas in mice. Using transwell assays, we investigated the effect of IGF-I and HGF on L3.6pl migration and invasion. We measured the induction of uPA and uPAR following treatment of cells with IGF-I and HGF using immunoprecipitation and Western blot analysis. The importance of uPA and uPAR on L3.6pl cell migration and invasion was studied by inhibiting their activities with amiloride and antibodies before cytokine treatment. In an orthotopic mouse model of human pancreatic carcinoma, we evaluated the effect of anti-uPAR monoclonal antibodies with and without gemcitabine on primary tumor growth, retroperitoneal invasion, and hepatic metastasis. IGF-I and HGF mediated cell migration and invasion in L3.6pl cells. In addition, IGF-I and HGF induced uPA and uPAR expression in L3.6pl cells. In vitro, blockade of uPA and uPAR activity inhibited IGF-I- and HGF-mediated cell migration and invasion. Treatment of mice with anti-uPAR monoclonal antibody significantly decreased pancreatic tumor growth and hepatic metastasis and completely inhibited retroperitoneal invasion. Our study shows the importance of the uPA/uPAR system in pancreatic carcinoma cell migration and invasion. These findings suggest that uPAR is a potential target for therapy in patients with pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=24744449559&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744449559&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-05-0946

DO - 10.1158/0008-5472.CAN-05-0946

M3 - Article

C2 - 16140945

AN - SCOPUS:24744449559

VL - 65

SP - 7775

EP - 7781

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 17

ER -